Animal health company ImmuCell Corp. (NASDAQ: ICCC) of Portland closed its full-year and fourth quarter 2015 with strong sales, which in turn created a backlog of orders for its First Defense product to prevent diarrhea and dehydration in newborn calves. Total sales increased 22% to $2.7 million in the fourth quarter of 2015 ended Dec. 31 compared to $2.2 million in the same period last year. That marked the 14th consecutive quarter of positive sales growth over the last 21 quarters compared to the same quarters the prior years. Net income in Q4 rose to $289,000, or 9 cents per diluted share, versus net income of $131,000, or 4 cents per diluted share, in 4Q2014. Read full story
Related Posts
Maine’s first mobile biolab starts tour of rural schools in Fort Kent
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
UMaine Augusta’s $1.75M medical lab training facility doubles student capacity
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
UNE receives grant to research state-threatened animal
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...